A retrospective analysis of borderline ovarian tumors in a Greek university hospital.
OBJECTIVE
The aim of this retrospective study was to analyze the pathologic and clinical characteristics of borderline ovarian tumors.


RESULTS
During the period from January 1993 up to December 2002 we found 93 cases of borderline ovarian tumors. The mean age of patients was 44.3 years (range 28.9-59.7 years); 77.4%, 10.8% and 11.8% of patients had Stage I, II and III, respectively. The histological outcomes revealed 52.7% of serous and 41.9% of mucinous origin; 44.1% underwent radical surgery, whereas 55.9% had unilateral salpingo-oophorectomy or cystectomy. The mean follow-up was 84 +/- 22 months. The overall five-year survival was 97.4% and 98% for mucinous and serous tumors, respectively. The survival rate was 100%, 90% and 81.8% in Stages I, II and III, respectively.


CONCLUSIONS
From our results it can be concluded that borderline ovarian tumors have a favorable prognosis even after conservative management.
Liapis
A
A
2nd Department of Obstetrics and Gynecology, Medical School, University of Athens, Aretaieion Hospital, Athens, Greece.
Bakalianou
K
K
Iavazzo
C
C
Salakos
N
N
Paltoglou
G
G
Kondi-Pafiti
A
A
D000328:Adult; D018394:CA-125 Antigen / Q000097:blood; D018395:CA-19-9 Antigen / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006115:Greece; D006785:Hospitals, University; D006801:Humans; D008499:Medical Records; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology* / Q000601:surgery; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000145:classification / Q000473:pathology* / Q000601:surgery; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate
D018394:CA-125 Antigen; D018395:CA-19-9 Antigen